연구성과로 돌아가기

2020 연구자 정보 (659 / 997)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Sheikholeslami, M.
(Sheikholeslami, M) ⓘ 		Babol Noshirvani Univ Technol, Dept Mech Engn, Babol, Iran
Babol Noshirvani Univ Technol, Renewable Energy Syst & Nanofluid Applicat Heat T, Babol, Iran
Babol Noshirvani Univ Technol, Dept Mech Engn, Babol Sar, Iran
Babol Noshirvani Univ Technol, Renewable Energy Syst & Nanofluid Applicat Heat T, Babol Sar, Iran ⓘ 		G-9034-2015
Sheikholeslami, Mohsen ⓘ
ⓘ 		[JCR상위 41.3] Convective MHD flow of hybrid-nanofluid within an elliptic porous enclosure
[JCR상위 56.1] Examination of CVFEM for nanofluid free convection MHD flow through permeable medium
[JCR상위 56.1] Heat transfer management of hybrid nanofluid including radiation and magnetic source terms within a porous domain
[JCR상위 12.5] Effectiveness of various shapes of Al2O3 nanoparticles on the MHD convective heat transportation in porous medium CVFEM modelling ⓘ 		SCIE ⓘ 12.5 PHYSICS, MULTIDISCIPLINARY
NANOSCIENCE & NANOTECHNOLOGY
CHEMISTRY, ANALYTICAL;CHEMISTRY, PHYSICAL;THERMODYNAMICS ⓘ 		sabirali@cuisahiwal.edu.pk;shafeehajizadehahmad@duytan.edu.vn;
ali_qau70@yahoo.com;houman.babazadeh@tdtu.edu.vn;
voduydat@tdtu.edu.vn;sabirali@cuisahiwal.edu.pk; ⓘ
Ahn, Myung-Ju
(Ahn, MJ) ⓘ 		Sungkyunkwan Univ, Div Hematol Oncol, Samsung Med Ctr, Sch Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ kihlee@chungbuk.ac.kr; ⓘ
An, Ho Jung
(An, HJ) ⓘ 		Catholic Univ Korea, Coll Med, Dept Internal Med, Div Med Oncol,St Vincents Hosp, Suwon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ kihlee@chungbuk.ac.kr; ⓘ
Bae, Woo Kyun
(Bae, WK) ⓘ 		교신저자 Chonnam Natl Univ, Coll Med, Dept Internal Med, Div Hematol Oncol,Hwasun Hosp, Hwasun, South Korea
Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial
[JCR상위 35.6] Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy ⓘ 		SCIE ⓘ 35.6 ONCOLOGY
MEDICINE, GENERAL & INTERNAL ⓘ 		infection@korea.ac.kr;drwookyun@jnu.ac.kr;
bwkang@knu.ac.kr;bwkang@knu.ac.krInkeun; ⓘ
Beom, Seung-Hawn
(Beom, SH) ⓘ 		Yonsei Univ, Dept Internal Med, Div Med Oncol, Coll Med, Seoul, South Korea ⓘ
ⓘ 		0000-0001-7036-3753
Beom, Seung-Hoon ⓘ 		[JCR상위 41.5] Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ infection@korea.ac.kr;drwookyun@jnu.ac.kr; ⓘ
Cho, Eun Kyung
(Cho, EK) ⓘ 		Gachon Univ, Dept Internal Med, Div Oncol, Gil Med Ctr, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ kihlee@chungbuk.ac.kr; ⓘ
Choe, Michael Sung Pil
(Choe, MSP) ⓘ 		제1저자 CHA Univ, Gumi CHA Med Ctr, Dept Emergency Med, Gumi, South Korea ⓘ
ⓘ 		0000-0002-1811-3295
CHOE, MICHAEL SUNG PIL ⓘ 		[JCR상위 41.5] Application of calcium nebulization for mass exposure to an accidental hydrofluoric acid spill ⓘ SCIE ⓘ 41.5 CRITICAL CARE MEDICINE;DERMATOLOGY;SURGERY ⓘ michaelchoe@hanmail.net;emmam@knu.ac.kr;kssuh@knu.ac.kr;kamshin@knu.ac.kr;pmkky@knu.ac.kr;jdw2000@daum.net;junram@nate.com;a345em@gmail.com;twilgiht2002@naver.com;drjeong79@naver.com;ryoo@knu.ac.kr; ⓘ
Choe, Yun-Mee
(Choe, YM) ⓘ 		Inha Sch Med, Dept Pediat Surg, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Pediatric Adenocarcinoma in Korea: A Multicenter Study ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ spkhy02@snu.ac.kr; ⓘ
Choi, Wonyoung
(Choi, W) ⓘ 		제1저자 Chonnam Natl Univ, Coll Med, Dept Internal Med, Div Hematol Oncol,Hwasun Hosp, Hwasun, South Korea ⓘ ABE-3359-2020
Choi, Wonyoung ⓘ 		0000-0002-8292-3903
Choi, Wonyoung ⓘ 		[JCR상위 41.5] Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ infection@korea.ac.kr;drwookyun@jnu.ac.kr; ⓘ
Chung, Ik-Joo
(Chung, IJ) ⓘ 		Chonnam Natl Univ, Coll Med, Dept Internal Med, Div Hematol Oncol,Hwasun Hosp, Hwasun, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Coll Med, Hwasun, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial
[JCR상위 13.4] Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial ocr ⓘ 		SCIE ⓘ 13.4 ONCOLOGY ⓘ infection@korea.ac.kr;drwookyun@jnu.ac.kr;
yhk0215@korea.ac.kr; ⓘ
Chung, Jae Hee
(Chung, JH) ⓘ 		Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat Surg, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Pediatric Adenocarcinoma in Korea: A Multicenter Study ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ spkhy02@snu.ac.kr; ⓘ
Heo, Tae Gil
(Heo, TG) ⓘ 		Inje Univ, Ilsan Paik Hosp, Dept Surg, Goyang, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Pediatric Adenocarcinoma in Korea: A Multicenter Study ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ spkhy02@snu.ac.kr; ⓘ
Ho, In Geol
(Ho, IG) ⓘ 		Yonsei Univ, Severance Childrens Hosp, Dept Pediat Surg, Coll Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Pediatric Adenocarcinoma in Korea: A Multicenter Study ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ spkhy02@snu.ac.kr; ⓘ
Hwang, Jun-Eul
(Hwang, JE) ⓘ 		Chonnam Natl Univ, Coll Med, Dept Internal Med, Div Hematol Oncol,Hwasun Hosp, Hwasun, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 41.5] Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ infection@korea.ac.kr;drwookyun@jnu.ac.kr; ⓘ
Im, Seock-Ah
(Im, SA) ⓘ 		Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea ⓘ 		J-5620-2012
Im, Seock-Ah ⓘ
ⓘ 		[JCR상위 41.5] Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant ⓘ SCIE ⓘ 41.5 ONCOLOGY ⓘ paojlus@hanmail.net;brcakorea@gmail.com; ⓘ
페이지 이동: